-
Vertex Pharmaceuticals' (VRTX) "Outperform" Rating Reaffirmed at William Blair
Source: Buzz FX / 13 Jan 2025 17:30:16 America/Chicago
Vertex Pharmaceuticals' (VRTX) "Outperform" Rating Reaffirmed at William Blair Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Vertex Pharmaceuticals ( NASDAQ:VRTX - Get Free Report ) 's stock had its "outperform" rat
Read more...